Annual Total Debt:
$808.74M-$16.41M(-1.99%)Summary
- As of today (May 31, 2025), BCRX annual total debt is $808.74 million, with the most recent change of -$16.41 million (-1.99%) on December 31, 2024.
- During the last 3 years, BCRX annual total debt has risen by +$215.50 million (+36.33%).
- BCRX annual total debt is now -1.99% below its all-time high of $825.15 million, reached on December 31, 2023.
Performance
BCRX Total debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Debt:
$794.99M-$13.76M(-1.70%)Summary
- As of today (May 31, 2025), BCRX quarterly total debt is $794.99 million, with the most recent change of -$13.76 million (-1.70%) on March 31, 2025.
- Over the past year, BCRX quarterly total debt has dropped by -$31.89 million (-3.86%).
- BCRX quarterly total debt is now -5.97% below its all-time high of $845.43 million, reached on September 30, 2023.
Performance
BCRX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total debt Formula
Total Debt = Short Term Debt + Long Term Debt
BCRX Total debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -2.0% | -3.9% |
3 y3 years | +36.3% | +29.7% |
5 y5 years | +855.4% | +832.6% |
BCRX Total debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -2.0% | +36.3% | -6.0% | +420.1% |
5 y | 5-year | -2.0% | +855.4% | -6.0% | +884.2% |
alltime | all time | -2.0% | >+9999.0% | -6.0% | >+9999.0% |
BCRX Total debt History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $794.99M(-1.7%) |
Dec 2024 | $808.74M(-2.0%) | $808.74M(-0.0%) |
Sep 2024 | - | $809.14M(-1.5%) |
Jun 2024 | - | $821.67M(-0.6%) |
Mar 2024 | - | $826.88M(+0.2%) |
Dec 2023 | $825.15M(+11.3%) | $825.15M(-2.4%) |
Sep 2023 | - | $845.43M(+2.2%) |
Jun 2023 | - | $827.63M(+9.6%) |
Mar 2023 | - | $755.36M(+1.9%) |
Dec 2022 | $741.45M(+25.0%) | $741.45M(+2.7%) |
Sep 2022 | - | $721.81M(+372.2%) |
Jun 2022 | - | $152.85M(-75.1%) |
Mar 2022 | - | $613.00M(+3.3%) |
Dec 2021 | $593.24M(+112.2%) | $593.24M(+252.0%) |
Sep 2021 | - | $168.54M(+4.1%) |
Jun 2021 | - | $161.88M(+2.5%) |
Mar 2021 | - | $157.92M(-43.5%) |
Dec 2020 | $279.50M(+230.2%) | $279.50M(+246.0%) |
Sep 2020 | - | $80.78M(-5.5%) |
Jun 2020 | - | $85.48M(+0.3%) |
Mar 2020 | - | $85.24M(+0.7%) |
Dec 2019 | $84.65M(+36.9%) | $84.65M(+0.2%) |
Sep 2019 | - | $84.52M(+1.9%) |
Jun 2019 | - | $82.93M(+5.2%) |
Mar 2019 | - | $78.85M(+27.5%) |
Dec 2018 | $61.82M(+13.0%) | $61.82M(+0.2%) |
Sep 2018 | - | $61.70M(+19.4%) |
Jun 2018 | - | $51.69M(-2.9%) |
Mar 2018 | - | $53.21M(-2.8%) |
Dec 2017 | $54.72M(+1.9%) | $54.72M(+0.4%) |
Sep 2017 | - | $54.52M(+0.7%) |
Jun 2017 | - | $54.16M(+0.4%) |
Mar 2017 | - | $53.94M(+0.4%) |
Dec 2016 | $53.72M(+78.0%) | $53.72M(+0.5%) |
Sep 2016 | - | $53.47M(+74.7%) |
Jun 2016 | - | $30.61M(+0.6%) |
Mar 2016 | - | $30.42M(+0.8%) |
Dec 2015 | $30.18M(+0.6%) | $30.18M(+0.6%) |
Sep 2015 | - | $30.00M(0.0%) |
Jun 2015 | - | $30.00M(0.0%) |
Mar 2015 | - | $30.00M(0.0%) |
Dec 2014 | $30.00M(0.0%) | $30.00M(0.0%) |
Sep 2014 | - | $30.00M(0.0%) |
Jun 2014 | - | $30.00M(0.0%) |
Mar 2014 | - | $30.00M(0.0%) |
Dec 2013 | $30.00M(0.0%) | $30.00M(0.0%) |
Sep 2013 | - | $30.00M(0.0%) |
Jun 2013 | - | $30.00M(0.0%) |
Mar 2013 | - | $30.00M(0.0%) |
Dec 2012 | $30.00M(0.0%) | $30.00M(0.0%) |
Sep 2012 | - | $30.00M(0.0%) |
Jun 2012 | - | $30.00M(0.0%) |
Mar 2012 | - | $30.00M(0.0%) |
Dec 2011 | $30.00M(>+9900.0%) | $30.00M(0.0%) |
Sep 2011 | - | $30.00M(0.0%) |
Jun 2011 | - | $30.00M(0.0%) |
Mar 2011 | - | $30.00M(>+9900.0%) |
Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2010 | - | $0.00(0.0%) |
Jun 2010 | - | $0.00(0.0%) |
Mar 2010 | - | $0.00(0.0%) |
Dec 2009 | $0.00 | $0.00(0.0%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2009 | - | $0.00(0.0%) |
Jun 2009 | - | $0.00(0.0%) |
Mar 2009 | - | $0.00(0.0%) |
Dec 2008 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2008 | - | $0.00(0.0%) |
Jun 2008 | - | $0.00(0.0%) |
Mar 2008 | - | $0.00(0.0%) |
Dec 2007 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2007 | - | $0.00(0.0%) |
Jun 2007 | - | $0.00(0.0%) |
Mar 2007 | - | $0.00(0.0%) |
Dec 2006 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2006 | - | $0.00(0.0%) |
Jun 2006 | - | $0.00(0.0%) |
Mar 2006 | - | $0.00(0.0%) |
Dec 2005 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2005 | - | $0.00(0.0%) |
Jun 2005 | - | $0.00(0.0%) |
Mar 2005 | - | $0.00(0.0%) |
Dec 2004 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2004 | - | $0.00(0.0%) |
Jun 2004 | - | $0.00(0.0%) |
Mar 2004 | - | $0.00(0.0%) |
Dec 2003 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2003 | - | $0.00(0.0%) |
Jun 2003 | - | $0.00(0.0%) |
Mar 2003 | - | $0.00(0.0%) |
Dec 2002 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2002 | - | $0.00(0.0%) |
Jun 2002 | - | $0.00(0.0%) |
Mar 2002 | - | $0.00(0.0%) |
Dec 2001 | $0.00(-100.0%) | $0.00(0.0%) |
Sep 2001 | - | $0.00(0.0%) |
Jun 2001 | - | $0.00(-100.0%) |
Mar 2001 | - | $3000.00(-69.4%) |
Dec 2000 | $9800.00(>+9900.0%) | $9800.00(-42.4%) |
Sep 2000 | - | $17.00K(-26.1%) |
Jun 2000 | - | $23.00K(-20.7%) |
Mar 2000 | - | $29.00K(>+9900.0%) |
Dec 1999 | $0.00(0.0%) | $0.00(0.0%) |
Sep 1999 | - | $0.00(0.0%) |
Jun 1999 | - | $0.00(0.0%) |
Mar 1999 | - | $0.00(0.0%) |
Dec 1998 | $0.00(-100.0%) | $0.00(0.0%) |
Sep 1998 | - | $0.00(0.0%) |
Jun 1998 | - | $0.00(0.0%) |
Mar 1998 | - | $0.00(-100.0%) |
Dec 1997 | $100.00K(-66.7%) | $100.00K(0.0%) |
Sep 1997 | - | $100.00K(-50.0%) |
Jun 1997 | - | $200.00K(0.0%) |
Mar 1997 | - | $200.00K(-33.3%) |
Dec 1996 | $300.00K(-50.0%) | $300.00K(-25.0%) |
Sep 1996 | - | $400.00K(0.0%) |
Jun 1996 | - | $400.00K(-20.0%) |
Mar 1996 | - | $500.00K(-16.7%) |
Dec 1995 | $600.00K(-33.3%) | $600.00K(-14.3%) |
Sep 1995 | - | $700.00K(+16.7%) |
Jun 1995 | - | $600.00K(-14.3%) |
Mar 1995 | - | $700.00K(-22.2%) |
Dec 1994 | $900.00K | $900.00K(0.0%) |
Sep 1994 | - | $900.00K(-18.2%) |
Jun 1994 | - | $1.10M(-8.3%) |
Mar 1994 | - | $1.20M |
FAQ
- What is BioCryst Pharmaceuticals annual total debt?
- What is the all time high annual total debt for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual total debt year-on-year change?
- What is BioCryst Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly total debt year-on-year change?
What is BioCryst Pharmaceuticals annual total debt?
The current annual total debt of BCRX is $808.74M
What is the all time high annual total debt for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual total debt is $825.15M
What is BioCryst Pharmaceuticals annual total debt year-on-year change?
Over the past year, BCRX annual total debt has changed by -$16.41M (-1.99%)
What is BioCryst Pharmaceuticals quarterly total debt?
The current quarterly total debt of BCRX is $794.99M
What is the all time high quarterly total debt for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly total debt is $845.43M
What is BioCryst Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, BCRX quarterly total debt has changed by -$31.89M (-3.86%)